Search

Displaying results 8221 - 8230 of 10000 in total

Drug
Milsaperidone
go.drugbank.com/drugs/DB24348
ApprovedInvestigational
[L56056] On February 20, 2026, milsaperidone was approved by the FDA for the treatment of Bipolar I Disorder and schizophrenia.[L56059] … [A275426, A202004] Similarly, milsaperidone acts as an antagonist at dopamine D2 and 5-HT2A receptors,[A275427] as well as other adrenergic, dopamine, and serotonin receptor subtypes.
Categories: Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A SubstratesSynonyms: (S)-Hydroxy iloperidone
Drug
LX-623
go.drugbank.com/drugs/DB33571
Investigational
Categories: Heterocyclic Compounds, 1-Ring, Heterocyclic Compounds, 2-Ring
Drug
AR-12
go.drugbank.com/drugs/DB33575
Investigational
Categories: Heterocyclic Compounds, 1-Ring
Drug
AS-602868
go.drugbank.com/drugs/DB33577
Experimental
Categories: Monoamine Oxidase A Inhibitors for interaction with Monoamine Oxidase A substrates, Heterocyclic Compounds, 1-Ring
Drug
AST-487
go.drugbank.com/drugs/DB33578
Experimental
Categories: Heterocyclic Compounds, 1-Ring
Drug
CEP-5214
go.drugbank.com/drugs/DB33586
Experimental
Categories: Heterocyclic Compounds, 2-Ring, Heterocyclic Compounds, 3-Ring
Drug
HMN-214
go.drugbank.com/drugs/DB33591
Experimental
Categories: Heterocyclic Compounds, 1-Ring
Drug
PF-337210
go.drugbank.com/drugs/DB33601
Investigational
Categories: Heterocyclic Compounds, 2-Ring
Drug
RWJ-67657
go.drugbank.com/drugs/DB33607
Experimental
Categories: Heterocyclic Compounds, 1-Ring
Drug
TAS-119
go.drugbank.com/drugs/DB33613
Investigational
Categories: Heterocyclic Compounds, 1-Ring